Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026)
Ascendis Pharma A's (ASND) quarterly Asset Utilization Ratio came in at 0.57 in Q1 2026, up 166.14% year-on-year from 0.21 in Q1 2025, and down 10.97% quarter-over-quarter from 0.64 in Q4 2025.
Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Ascendis Pharma A has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.57 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.57, up 166.14% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.57 (up 166.14% YoY), and the FY2025 annual result was 0.34, up 68.43% from the prior year.
- Asset Utilization Ratio came in at 0.57 for Q1 2026 at Ascendis Pharma A, down from 0.64 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q4 2025 to a low of 0.04 in Q4 2022.
- The 5-year median for Asset Utilization Ratio is 0.21 (2025), against an average of 0.32.
- Across the five-year window, Asset Utilization Ratio jumped 886.53% in 2023 and plunged 59.96% in 2025, its largest moves.
- Ascendis Pharma A's Asset Utilization Ratio stood at 0.04 in 2022, then surged by 886.53% to 0.44 in 2023, then sank by 52.18% to 0.21 in 2024, then soared by 205.9% to 0.64 in 2025, then slipped by 10.97% to 0.57 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.57 (Q1 2026), 0.64 (Q4 2025), and 0.62 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn | 0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.46 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 0.53 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.07 |